ReEir Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.7M

  • Investors
  • 9

ReEir General Information

Description

Developer of a regenerative medicine platform designed to restore the bond between patients and society by treating serious illnesses with cell therapies derived from blood samples. The company offers innovative, simple, blood-based treatments, enabling patients with severe conditions to regain health.

Contact Information

Website
www.re-eir.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12 Floor Garden Tower, 1-6-1 Roppongi
  • Tokyo
  • Minato-ku
  • Japan
+81
Primary Industry
Drug Discovery
Parent Company
Vertical(s)
Corporate Office
  • 12 Floor Garden Tower, 1-6-1 Roppongi
  • Tokyo
  • Minato-ku
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ReEir Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 17-Jul-2025 $4.7M Completed Generating Revenue
2. Merger/Acquisition 09-Dec-2024 Completed Generating Revenue
1. University Spin-Out 29-Sep-2017 Completed Startup
To view ReEir’s complete valuation and funding history, request access »

ReEir Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ReEir FAQs

  • When was ReEir founded?

    ReEir was founded in 2017.

  • Where is ReEir headquartered?

    ReEir is headquartered in Minato-ku, Japan.

  • What is the size of ReEir?

    ReEir has 6 total employees.

  • What industry is ReEir in?

    ReEir’s primary industry is Drug Discovery.

  • Is ReEir a private or public company?

    ReEir is a Private company.

  • What is ReEir’s current revenue?

    The current revenue for ReEir is .

  • How much funding has ReEir raised over time?

    ReEir has raised $4.7M.

  • When was ReEir acquired?

    ReEir was acquired on 17-Jul-2025.

  • Who acquired ReEir?

    ReEir was acquired by Hisamitsu Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process